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American and Ukraine
Abstract
With the growing population of elderly individuals throughout the world, the study of their emotional distress
is ever poignant to society. This is especially true when these individuals have cognitive impairment. The
research, in regards to Eastern European individuals, is lacking. To gain a better understanding of this
understudied population, elderly people with Mild Cognitive impairment (MCI) from both Ukraine and the
United States were studied. It was found that the anxiety rates of the Ukrainian MCI group were significantly
higher than both the United States MCI group and the Ukraine control (p = 0.004). Purpose The purpose of
this research was to examine the relationships between cognition and anxiety among individuals with MCI in
Ukraine versus those in the United States. In addition to describing anxiety levels in individuals with MCI,
research questions included ( I ) is there a difference in anxiety among individuals with aMCI vs. naMCI and
(2) is there a difference in anxiety among individuals with MCI in the Ukraine versus the United States?
These populations were chosen to describe what differences may been seen within a lower- middle income
country and a high income country in terms of reported anxiety among individuals with MCI. Methods
Participants were asked demographic questions and a Symptom Questionnaire as well as were evaluated using
the Montreal Cognitive Assessment. Comparisons between anxiety and the type of MCI, amnestic (n = 90)
or nonamnestic (n .., 67), were made for both s MCI AND ANXIETY IN THE US AND UKRAINE groups
of elderly individual as well as comparisons between Ukrainian MCI (n = 66) and control groups (11- 66),
and an American MCI group (n = 91). These were both community based convince samples who were
recruited from a neurology clinic (American) or a primary- care network (Ukranian). Results: It was shown
that there were no significant differences in anxiety levels between naMCI and aMCI groups. ANOVA
comparison demonstrated that Ukrainian MCI individuals had significantly (p "" 0.004) higher levels of
anxiety than subjects with MCI in America and subjects without MCI in the Ukraine. There were no
significant differences in anxiety levels between subjects with MCI in the United States and subjects without
in the Ukraine. This being said, I 0.6% (n "" 7) of the Ukrainian MCI group and 4% (11 = 4) American MCI
group were in the substantial to severe anxiety level range while the Ukrainian
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Abstract_ 
With the growing population of elderly individuals throughout the world, the study of 
their emotional distress is ever poignant to society. This is especially true when these 
individuals have cognitive impainnent. The research, in regards to Eastern European 
individuals, is lacking. To gain a better understanding of this understudied population, 
elderly people with Mild Cognitive lmpainnent (MCI) from both Ukraine and the United 
States were studied. It was found that the anxiety rates of the Ukrainian MCI group were 
significantly higher than both the United States MCI group and the Ukraine control (p = 
0.004). 
Purpose 
The purpose of this research was to examine the relationships between cognition and 
anxiety among individuals with MCI in Ukraine versus those in the United States. In 
addition to describing anxiety levels in individuals with MCI, research questions included 
(I)  is there a difference in anxiety among individuals with aMCI vs. naMCI and (2) is 
there a difference in anxiety among individuals with MCI in the Ukraine versus the 
United States? These populations were chosen to describe what differences may been 
seen within a lower- middle income country and a high income country in terms of 
reported anxiety among individuals with MCI. 
Methods 
Participants were asked demographic questions and a Symptom Questionnaire as well as 
were evaluated using the Montreal Cognitive Assessment. Comparisons between anxiety 
and the type of MCI, amnestic (n = 90) or nonamnestic (n .., 67), were made for both 
s 
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groups of elderly individual as well as comparisons between Ukrainian MCI (n = 66) and 
control groups (11- 66), and an American MCI group (n = 91). These were both 
community based convince samples who were recruited from a neurology clinic 
(American) or a primary- care network (Ukranian). 
ResuUs 
It was shown that there were no significant differences in anxiety levels between naMCI 
and aMCI groups. ANOVA comparison demonstrated that Ukrainian MCI individuals 
had significantly (p"" 0.004) higher levels of anxiety than subjects with MCI in America 
and subjects without MCI in the Ukraine. There were no significant differences in anxiety 
levels between subjects with MCI in the United States and subjects without in the 
Ukraine. This being said, I 0.6% (n "" 7) of the Ukrainian MCI group and 4% (11 = 4) 
American MCI group were in the substantial to severe anxiety level range while the 
Ukrainian control had 0% in this range. These results demonstrate the need for future 
exploration of this topic. The findings of this research also demonstrate the clinical 
significance of screening for anxiety in cognitively impaired individuals especially in 
those from Eastern European countries such as Ukraine. 
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The Effect of Mild Cognitive lmpainnent on Anxiety in Older Adults in America and 
Ukraine. 
Mild Cognitive Impairment (MCI} is a globally studied symptom set that exists 
through the following parameter: individuals demonstrate cognitive impainnent with 
minimal impainnent of instrumental activities of daily living (IADL) (Peterson et al., 
2018). These criteria are used widely within the preexisting research and are applied 
within clinical classifications. Definitions of MCI are numerous and may differ 
depending on many factors (Stephan et al., 2008). Some are expanded to include memory 
impainnent, commonly referred to as subjective memory complaints (SMC). This is 
attributed primarily to amnestic MCI (aMCI) which refers to patients who experience 
memory loss alongside their MCI diagnosis. Other tenns have also been used such as 
cognitively impaired, no dementia (CIND). This is relates to nonamnestic MCI (naMCI} 
which describes patients who report no memory problems with their MCI diagnosis. The 
DSM-5 refers to MCI as mild neurocognitive disorder (nMND) (Ganguli, 2011) which 
may also include other diagnosis beyond MCI. 
Anxiety already effects 4 to 6% of the Ukrainian population, with the prevalence 
increasing over the individual's lifespan (Bromet et al., 2005; Ruscio et al., 2017). In 
other European countries this prevalence can be seen as high as I 0% in a population 65 
and older (Riedel-Heller, Busse, & Angermeyer, 2006). In contrast, the anxiety levels of 
American individuals is about 8% (Ruscio et al., 2017) and within populations of 
cognitively normal older adults, 5% (Geda et al., 2008; Peters et al., 2012). This number 
is even higher within MCI communities. 
Significance 
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MCI patients are more prone to psychological distress, especially anxiety, than 
their cognitively intact counterparts (Ausen, Edman, Alrnkvist, & Bogdanovic, 2009; 
Palmer et al., 2007). Peterson and colleagues (2018) has identified that the prevalence of 
MCI is 16% for individuals aged 60 years and older, which increases over age, peaking at 
38%. This has been supported by other studies which show in European specific cohorts 
MCI has an incidence rate of 19% in populations 65 and older (Riedel-Heller et al., 
2006). Up to 40% of individuals with MCI have been shown to have anxiety (Palmer et 
al., 2007; Taragano, et al., 2009). Beyond geographical difference, anxiety levels between 
aMCI and naMCI populations differ with nonarnestic populations, showing slightly 
higher prevalence of anxiety (Geda et al., 2008). 
Similar populations have often been used to study the relationship between 
anxiety and MCI, primarily Western European and North American populations. Little 
has been done to compare anxiety levels between MCI populations from areas which are 
dissimilar geographically and/or socially. More specifically, the study of anxiety and 
MCI has been severely limited in Eastern European populations. The literature presented 
here involving American and Ukrainian populations will allow for the understanding of 
symptoms of MCI and if the treatments for MCI and the comorbid psychological 
symptoms can be applied to these dissimilar areas. In a clinical setting these findings 
could be used to inform practitioners not only of the severity of symptoms this population 
may face but also the prominence of these symptoms. This could motivate the 
practitioner to screen for psychological illness with patients with MCI. This study could 
also be used as a guide for future research. Eastern European studies regarding anxiety in 
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MCI populations is severely limited. Using this research, future studies could work to till 
this void. 
Purpose 
The purpose of the study of this American and Ukrainian sample allowed for the 
1) report of anxiety in MCI and control populations 2) discernment of anxiety rates 
between aMCI and naMCI 3) differentiation of anxiety between MCI patients, dependent 
on geography. To address these aims, it was hypothesized that the patients with aMCI 
will have significantly more anxiety than naMCI populations. Also, it is hypothesized 
that the Ukrainian MCI population will have significantly more anxiety than the 
American MCI population. 
Theoretical Framework 
The study of anxiety within a MCI population is important. Unfortunately, there 
are no models which explicitly explain cognition's role in anxiety. Rather cognition must 
be inferred through an individuals' ability to correctly manage the stress which results 
from life events, life stress, and self-concept. Executive function must be used to 
appropriately address these concepts and therefore impainnent of executive function, as 
seen in MCI, would increase anxiety. Use of life events, life stress, and self-concept can 
be seen through the model of coping developed by Pearl in, Menaghan, Lieberman, and 
Mullan ( 1981 ). There are many stress and coping models. Peralin and colleagues' model 
was chosen due to its inclusion of life stress and life events. These factors may change as 
a result societal influences, making it apt for answering the research questions presented 
here. This model claims that changes in life events, life stress, and self-concept can all 
lead to stress. Effective coping and strong social supports can interrupt this progression 
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into stress. Through the framework presented here there is a link made to anxiety by the 
life events, stress, and self-concept that an individual may be unable to handle as well as 
a normal control. This connection is made in combination with an increase in severity of 
unpleasant life events and stressors which may be present in Ukraine. 
LIFE 
EVENTS 
LIFE 
STRAIN 
SELF­
CONCEPT 
SOCIAL 
SUPPORTS 
STRESS 
Biochem1cal 
Phys1ological 
Figure/. Model of Pearlin and colleagues' model of coping and stress ( 1981) as 
presented in A very (2014) 
Patients with MCI may overestimate their abilities to function (Fragkiadaki et al., 
2016), causing them to not seek help when it might be beneficial. Some executive 
function tasks (driving, telephone use, and financial management) are impaired in MCI 
patients when compared to cognitively normal adults (Farias et al., 2006; Okonkwo et al., 
2009). Patients with MCI are often unaware of the deficits they have (Orfei et al., 2010; 
Vogel et al., 2004) but that does not mean that problems preforming actions do not 
eventually cause anxiety. An individual may not be able to drive as well as another older 
adult and crash their car. Whether they are aware of the executive function deficit which 
contributed to the crash or not, this would still cause anxiety. This is only increased when 
the frequency of improper driving is higher than in normal older adults. This is just one 
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example of how the life events created by executive function deficits could increase the 
likelihood of anxiety. Improper knowledge of these deficits can also mean that the 
patients are unwilling to seek help through social supports and incorrectly respond to the 
situation. 
Another issue is the limited resources that may be awarded to individuals. In 
Eastern Europe, specifically Ukraine, these social supports may be limited especially due 
to the political instability seen within the country (D'Anieri, 2015; Lain, 2016). This may 
block access to social supports while increasing life stress for all individuals but 
especially those with MCI. Patients with MCI may be unable to successfully access these 
remaining social supports as well as a cognitively normal adult would. 
Literature Review 
Mild Cognitive Impairment is a symptom set which afflicts many of the world's 
older adult population. This being said, it was left largely unexplored until the late 
l 990's. In the last 20 years the research has blossomed, expanding in volume 
tremendously. The aim of this review is to highlight parts of this large pool mainly 
responding to the questions: ( 1) What is MCI? (2) Is MCI worthy of independent study? 
(3) What is anxiety? (4) Is there a relationship between MCI and Anxiety? (5) If this 
relationship exists, how does it address Ukrainian populations? (6) What research has 
been done regarding MCI, anxiety, and Ukraine or its boarder states? 
What is MCI? 
Many elderly people complain of memory loss and it is considered a part of 
normal aging. This seemingly normative aging can, when studied carefully, follow 
trajectories that lead to mild cognitive impairment (MCI). This clinical condition can 
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effect up to anywhere from 16 to 38% of the population (Juncos- Rabadan et al., 2014; 
Peterson et al., 2018; Riedel-Heller et al., 2006). The definitions used for diagnosis and 
the resulting terminology can also be similar memory associated diseases to MCI. 
(Wilson, Beckett, Bennett, Albert, & Evans, 1999). Some of these include Age Consistent 
Memory Impairment, Age Related Cognitive Decline, Benign Senescent Forgetfulness, 
Cognitive Impairment No Dementia, and Mild Neurocognitive Disorder (Stephan et al., 
2008). Consistent with some of these definitions, MCI is seen as intermediate of 
dementia. This definition was explored by Grundman and colleagues (2004). They 
claimed MCI is deficit in memory functions that is intermediate to the function of a 
normal aging person and a person with Alzheimer's dementia (AD). This occurs without 
faults in other cognitive domains (Grundman et al., 2004). This transition from MCI to 
Alzheimer's disease is typically consistent with definitions which focus on the presence 
of memory impairments (aMCI) (Schmidtke & Hermeneit, 2008). Others have contested 
these claims and state that MCI can exist within and outside of a dementia continuum 
(Peterson et al., 2018). Finally, neither of these definitions mentions a required memory 
loss symptom. With these components added together, there are many ways to classify 
MCI. It has been seen within the literature that there is use of at least 17 definitions when 
studying MCI (Stephan et al., 2008). 
MCI can also be subtyped multiple ways. Here it is divided between amnestic 
MCI and nonamnestic, implying memory complaints or lack of those complaints 
(Peterson et al., 20 t 8). Others have subtyped between multi-domain and single domain. 
This means that the patients experience multiple deficits associated with their MCI 
diagnosis (multi- domain) or a singular deficit (single domain) (Peterson et al., 2018). 
t2 
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These criteria can be combined with amnestic or nonamnestic criteria to show how many 
types of impairment an individual may have and whether memory problems are present. 
Other research have grouped individuals with presence of executive impairment (exMCI) 
or lack of this symptom (non-ex MCI) (Rosenberg et al., 2011 ). Some patients do not 
meet any subtype and are classified as undifferentiated (Mansbach, Mace, & Clark, 
2016). These validity of these subtypes have been brought into question, which some 
individuals stating that all or some of the subtypes are not accurate (Han et al., 2012; 
Klekociuk & Summers, 2014). Although this may be true, they are still used throughout 
clinical practice and therefore are important for study. 
Is MCI Worthy of Independent Study? 
Much of the research today focuses on MCI as an etiological factor of 
Alzheimer's disease (AD) or other non- Alzheimer's dementias (Jicha et al., 2006) but, 
little concerns MCI exclusively or MCI as a stagnant state within a geriatric population. 
Implied progression to AD or other dementias is not always accurate. Elfgren and 
colleagues (2010) showed that 60% of their participants at a three year follow up had 
maintained their MCI diagnosis while only 27% had progressed to a dementia. These 
results are not anomalies. Other studies have shown that 53 to 61 % of participants 
maintained their MCI diagnosis over similar lengths of time (Wahlund, Pihlstrand, & 
Jllnhagen, 2003; Wolf et al., 1998). These show that the study of MCI independent of the 
dementia spectrum is as relevant as those that study MCI as a prodrome of dementia 
MCI as a progression to dementia is shown even more so by the literature which 
focuses on neuropsychiatric symptoms as a marker for progression into AD (Jicha et al., 
2006; Palmer et al., 2007; Rosenberg et al., 2013). Similarly to the general diagnosis, this 
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research does little to explain these symptoms in regards to MCI. Furthermore, many 
studies focus on the prevalence of depression within the MCI population rather than 
anxiety (Van der Mussele et al., 2013). 
This improper focus on MCI caries a heavy weight within peoples' lives. People 
are getting diagnosed with MCI every day. Despite views regarding progression or lack 
thereof, the truth is by not making this a focal point there is a disservice done to 
individuals. 
What is Anxiety? 
Anxiety is described by many, including Freud, as a feeling. This emotional state 
included feelings of apprehension, tension, nervousness, and worry accompanied by 
physiological arousal (Spielberger, 2010). Similarly to MCI there are many different 
terms associated with anxiety, each with their own implications. The over- arching 
distinction of all diagnosable categories is whether there is a constant feeling of anxiety 
(trait) or a current anxious feeling (state) (Bernstein & Eveland, 1982). These terms have 
much different implications. Trait anxiety means a constant and mostly stable anxious 
feeling while state anxiety is influenced by "transitory situational stress" (Spielberger. 
1971 ). In the data presented here, an anxiety state was assessed. 
Is There A Relationship Between MCI And Anxiety? 
Anxiety is very important factor in the lives of many individuals with MCI. These 
patients are more prone to anxiety, than their cognitively normal peers (Ausen ct al.. 
2009; Palmer et al., 2007). It has been shown that the odds of having anxiety symptoms 
are increased by 1.43 to 16.5 for individuals having an MCI diagnosis (Yates, Clare, & 
Woods, 2013). Up to 40% of individuals with MCI have been shown to have anxiety 
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(Palmer et al., 2007; Taragano et al., 2009). A study concerning aMCI and naMCI 
exclusively showed that the anxiety rate of a cohort consisting these two subtypes was 
47% (Ellison, Harper, Berlow, & Zeranski, 2008). Research shows that anxiety for 
individuals with MCI is a primary result of their diagnosis (Frank et al., 2006). This 
means not only is anxiety wide spread but can be caused directly from an MCI diagnosis. 
These studies have been performed with primarily American or Western European 
cohorts (Frank et al., 2006; Palmer et al., 2007; Taragano et al., 2009). The data on 
people outside of these populations shows different results. A study with East- Asia 
cohort found the prevalence of anxiety to be 64% within MCI patients (Yatawara, Hiu, 
Tan, & Kandiah, 2018). This data was collected in Singapore, which is more 
economically sound than Ukraine. 
For the individual who is diagnosed with MCI, life expectancy can be different 
than their cognitively normal counterparts. This disparity based on a diagnosis could 
explain these increased anxiety rates. Research has shown that the individuals can have 
almost double the mortality rate of unaffected older adults within the same age range 
(Guehne, Agermeyer, & Riedel-Heller, 2006). A recent study has shown that these 
individuals can lose, on average, 5.2 years (male) or 7.8 (female) of their life compared to 
normal 70-year olds (Strand et al., 2018). This data is mixed but does show that diagnosis 
can carry a heavy burden for the patient. Knowing that death is potentially near could 
effect a patients' self-concept and be a negative life event. These have been shown 
through the framework created by Pearlin and colleagues ( 1981 )  to increase life stress. 
If This Relationship Exists How Does It Address Ukrainian Populations? 
1 5  
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Anxiety may be very different in countries like Ukraine, which are low- and 
middle-income countries (LM!Cs). Countries that are identified as LMIC have higher 
demographic instability and have less infrastructure designated to assist affected 
populations (Prina, Ferri, Guerra, Bayne, & Prince, 201 1 a). The data regarding older 
adults' anxiety rate is mixed within the research that studies LMIC specific cohorts 
(Prina, Ferri, Guerra, Bayne, & Prince, 201 l b). Still little data is collected on MCI 
populations and their psychological distress within these populations. Even more so, the 
data is limited regarding a comparison between high-income countries and LMICs. 
Because most psychological tests are developed with populations from high-income 
countries, studies of differences between these populations would firm reliability. 
What Research Has Been Done Regarding MCI, Anxiety, And Ukraine or its 
Boarder States? 
One study does exist within a Ukrainian population regarding neuropsychological 
symptoms in MCI patients. An attempt to find research on this topic in Ukrainian border 
states and the ethnic groups which make up these surrounding studies was unsuccessful. 
The only study which regarded a similar topic to what was researched here was an 
exploration of mild neurocognitive disorders (MNCDs) (Levada, Cherednichenko, & 
Troyan, 201 7). In terms of this study, the author's claim MN CDs are congruent to MCI 
criteria. They study this in terms of two different subtypes, Alzheimer's disease and 
subcortical vascular, and their relations to neuropsychiatric symptoms. It was found that 
one group, the Alzheimer's group, had significantly more anxiety than the cognitively 
normal comparison. This study does little to show MCI as we are trying to explore it. Not 
only does this study not focus on the MCI criteria we used, it also does not the same 
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subtype classification used here. This makes the results, although displaying high anxiety 
for one subtype, difficult to compare to this research. Unfortunately, it was the only data 
that could be found regarding MCI, anxiety, and Ukraine or any of its bordering states. 
Conclusion 
The information that has been collected in recent years regarding MCI has left a 
lot of questions in its wake. One of the leading questions is the prevalence, effect, and 
cause of co-morbid psychological issues. Addressing these, in particular anxiety, is 
important. Currently data regarding this relationship is primarily done on American or 
Western European countries. This leaves the majority of the world out of the equation. 
Furthermore, because the treatments developed for both MCI and anxiety are developed 
in these Western populations, the treatment may be ineffective. Beyond a cultural 
difference, the economic status of the Western countries studied and the countries that are 
not included in the research are often very different. Research done to assess this 
disparity could further the clinical effectiveness treatment has cross- culturally. 
Method 
Data was collected after institutional review was given on 223 adult patients 55 
and older. This data was collected among both an American MCI population (US MCI) 
and a Ukrainian MCI population (UA MCI) and control population (UA control). 
Participants were excluded if they had dementia or MCI present with a significant 
medical or psychiatric diagnosis, for these may complicate or mask the MCI diagnosis. 
The individual methods for the collection of each group is specified below. 
American. A convenience sample of9 l community dwelling adults were 
recruited from an outpatient neurology clinic. This included only MCI patients who were 
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diagnosed by a physician with a diagnosis which was supported by neuropsychological 
testing. No control was used in this population. Recruitment occurred over 62 weeks and 
started in July 2013. Patients were identified by staff at the clinic and asked to participate 
in the study directly after their visit. Data collection and consent occurred with the Pl, 
who was unaffiliated with the clinic, in an unused room at the clinic. 
Ukrainian. A convenience sample of 1 32 community dwelling adults who were 
both MCI (n = 66) and non-MCI (n "" 66) were used. The MCI population had a 
physician diagnosis which was supported by neuropsychological testing (Montreal 
Cognitive Assessment). Recruitment occurred in 2016 and came from a primary- care 
physician network which was used by all the patients. From this sample 37 were 
excluded by a physician based on the inclusion/exclusion criteria. The subjects were 
provided with a written consent fonn which was approved by Lviv Regional Hospital 
(Lviv, Lviv Oblast, Ukraine) Human Subjects Research Program. 
Procedure 
All groups were given MoCA (version 7.1) either to confinn eligibility 
(Ukrainian) or as part of the testing protocol. This protocol also included demographic 
survey along with The Kellner Symptom Questionnaire (SQ) (Kellner & Sheffield, 
1973). This protocol was administered by the Pl in both cases. More tests were 
administered to the American population but they were not be used in this analysis. The 
resulting data was combined, anatomized, and re-analyzed in specific regard to anxiety. 
SPSS was used in the analysis. Chi squared was used to analyze categorical variables 
while a one way ANOV A was used for comparison between means. Results from the 
1 8  
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ANOV A were verified using a Tukey HSD post hoc analysis. This was approved by IRB 
and the Pl underwent Human Subjects training. 
Instruments 
Demographic Survey. The demographic survey was used to assess age, gender, 
length of diagnosis, race/ethnicity, educational level, marital status, religious affiliation, 
and socioeconomic status. These all could potentially affect the psychological distress of 
the subject and allows for their analysis. 
Kellner Symptom Questionnaire. The Kellner Symptom Questionnaire was 
used to measure psychological distress, where higher scores indicated increased 
psychological distress. The SQ contains 92 items, 68 of which asses symptoms of 
psychological distress and 24 of which are antonyms testing psychological well- being. 
Subscales of the SQ were also used to assess depression, anxiety, anger-hostility, and 
somatic symptoms. This test has been validated in English and was chosen for it's largely 
yes.Ina response type along with its reliability within clinical populations with low verbal 
skills (Keller, 1987). 
Montreal Cognitive Assessment. The Montreal Cognitive Assessment is used 
for screening for MCI. This tool is in English but has been well validated and accurately 
translated to Ukrainian, as well as other languages. It is particularly useful in assessing 
MCI because other neuropsychological tests do not have the same acuity for this subtle 
symptom set. In specificity, it assess attention, memory, language, visual-spatial skills, 
concentration, orientation, and executive functions. Lower scores on this test indicate 
higher levels of cognitive impairment. The MoCA was chosen for his high validity and 
sensitivity. 
19 
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All three tests were given in English to the American population. Both the 
demographic survey and the SQ were translated from English into Ukrainian by a 
certified translator, and were translated back into English by a separate certified translator 
to ensure accuracy. These were administered the Ukrainian population along with the 
MoCA which had been previously translated 
Results 
Of the population of 223 adults included within our study 89 were male (US MCI 
= 89, UA MCI = 22, UA control = I I), I 16 were female (US MCI = 35, UA MCI = 35 
UA control = 46), and 18 were unspecified (US MCI = 0, UA MCI = 9, UA control =- 9). 
There was a significant difference in the ratio of men than women among the groups 
included, primarily seen within the US MCI population, x2(4) =- 39.92 (p < 0.001). 
Within the two MCI groups 67 had naMCI symptoms (US = 39, UA ; 28) while the 
other 90 had aMCI (US • 52, UA = 38). Overall, there was not significantly more 
individuals with naMCI than aMCI in the US MCI vs. UA MCI groups, x2 ( I )  .,. 0.003 (p 
= 0.957). Minimum age within all groups was 54 with the maximum being 89. Analysis 
demonstrated that a significant difference among the groups in terms of age, F(2) = 48.77 
(p < 0.001). Tukey HSD showed that the US MCI and UA control were significantly 
different in age (MD ::::i 1 1 .74, p > 0.001 ), along with US MCI and UA MCI (MD = 8.45 p 
< 0.00 I). UA MCI and UA control were also significantly different in age (MD "" 3.29, p 
= 0.041). Minimum education within all groups was 4 years with a maximum of 35 years, 
F(2) = 4.39 (p =- 0.014). Post hoc analysis via Tukey HSD showed that education was not 
significantly different between UA MCI and UA control (MD = 1.35, p = 0.075) and 20 
MCI AND ANXIETY IN THE US AND UKRAINE 
between US MCI and UA control (MD = 0.28, p = 0.876) but was between US MCI and 
UA MCI (MD = 1.63,p "" 0.013). 
Table 1. Participant Demographics. 
Demographic MCI US MCI UA Control UA Significance (n = 124) (n = 66) (n = 66) Test 
(v2) 
Gender • D < .0001 
Male 89 22 I I  
Female 35 35 46 
Unspecified 0 9 9 
MCI TVDC D = .951 
naMCI 39 28 
aMCI 52 38 
Nole: •p<0.()5 
Beyond demographics other results were analyzed to test the hypotheses 
presented. As expected, MoCA total scores were different between the test groups and 
the control, F(2) c 6 1.45 (p < 0.00 I). Tukey HSD showed that a significant difference 
exists between US MCI and UA Control (MD = 4.55, p < 0.00 I) and UA MCI and UA 
Control (MD =- 5.45, p < 0.00 I), as was expected. MoCA scores did not vary significantly 
between the MCI populations (p = 0.168). MoCA total scores were also compared 
between MCI types and control. This showed, unsurprisingly, that there were significant 
differences among the groups, F(2) = 59.13 (p < 0.001). Tukey HSD showed that there 
was a significantly different MoCA scores between the control and both the naMCI (p < 
0.00 I )  and the aMCI (p < 0.00 I)  populations. The MoCA scores in the naMCI and aMCI 
(p = 0. 106) were not significant. 
Anxiety in terms of a total anxiety subscale was also found to be significantly 
different among the three groups, F(2) = 6.16 (p = 0.003). Post hoc analysis showed that 
2 1  
MCI AND ANXIETY IN THE US AND UKRAINE significant difference occurred between US MCI and UA MCI (MD = 2.57,p -= 0.014) and between UA MCI and UA Control (MD = 1 . 1 9, p = .007) but not between the two US MCI and UA Control (p = 0.896). Overall, an ANOV A comparison demonstrated that UA MCI had significantly higher anxiety than US MCI and UA control (p = 0.004). Clinical anxiety was also considered and broken up into nonnal, moderate, and substantial- severe and considered with both location and MCI type. There was not a significantly different number of individuals in each category in either the MCI US, MCI UA, or control UA groups x.2(8) = 1 2.20 (p - 0. 14). Although none of these proved statistically significant it should be noted that none of the controls tested within the substantial- severe range (See Figure 2). In fact, 1 0.6% (n = 7) of the UA MCI group and 4% (11 = 4) US MCI group were in the substantial to severe anxiety level range. Further divide into subtypes and location the percentages of participants who were in the substantial- severe range are as follows: UA naMCI 14% (n = 4), UA aMCI 8%, (n = 3), US naMCI 6%, (11 = 3), and US aMCI 3% (11 = I). 
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Figure 2. Severity of reported anxiety symptoms in MCI patients according to location 
and subtype 
Discussion 
Anxiety in terms of MCI throughout the world is an important area of study. The 
aims of this study was as follows: ( I )  describing anxiety levels in individuals with MCI 
and those in a control population, (2) finding a difference, if present, in anxiety among 
individuals with aMCI vs. naMCI, and (3) analyzing reported anxiety among individuals 
with MCI in the Ukraine versus the United States. 
Aim One 
The anxiety levels of those with MCI in the United States was not significantly 
different. The UA MCI group had the highest anxiety level and did vary significantly 
from these two groups. This is a surprising result, it was hypothesized that both the UA 
and US groups would have greater anxiety than the control. Theories surrounding these 
results are explained under Aim Three. 
Aim Two 
The aMCl and naMCI subtypes did not vary in anxiety, despite the location of the 
participants. This result did not support out hypothesis, though it is congruent with 
research done previously in similar populations (Rosenberg et al., 201 1; Rozzini et al., 
2008). The goal of this aim was to assess whether cultural, economic, or geographical 
influence may affect one subtype, in terms of anxiety, more than the other. These results 
show that these factors did not significantly affect the reported anxiety rates of one 
subtype compared to the other. These results could also mean that there was a mediating 
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variable, like chronic illness, brain injury or others, which were not accounted for in the 
data. 
Aim Three 
The relationship, in terms of anxiety, between the UA MCI group and the UA 
control group was expected. As shown in previous studies, MCI groups have significantly 
more anxiety than control groups when the data is collected in similar populations 
(Palmer et al., 2007; Peters et al., 2012). This data is congruent with the research done 
here. There is, unexpectedly, a significant difference in reported anxiety between US 
MCI and UA MCI. On the same note, there is no significant difference between US MCI 
and UA control. To explain these anomalies I present three theories: inability to access 
materials to assist symptom management, increased death related anxiety, and inability 
for the Symptom Questionnaire to account for cultural variance. 
The first of which relates to the access to materials an individual may need to 
successfully manage their MCI diagnosis. Individuals with MCI often have damaged 
executive function which results in impairment of some tasks (Farias et al., 2006; 
Okonkowo et al., 2009) Beyond this, the individuals may have significantly different 
perception of their deficits than a cognitively normal control (Orfei et al., 2010; Vogel et 
al., 2004). Because these deficits are there, and the individual may not have accurate 
perception of them, they may not harness the resources that are available to them. This 
could leave the individual facing problems that they are unprepared for and cannot 
accurately attribute to a deficit. These life events that cannot be appreciated normally can 
cause undue anxiety in an individual's life. This may affect all individuals with MCI and 
cause them to have more anxiety than controls, as seen in the literature (Ausen et al., 
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2009; Palmer et al., 2007). Increased anxiety is exaggerated even more when the person 
has less access to help because of a lack of government supplied resources. This is seen 
predominantly within countries classified as LIMCs, which includes Ukraine, because 
these governments have less systematic facilities designed to assist these populations. 
This may affect the Ukraine even more than most LIMCs because the political instability 
the country is currently facing (D' Anieri, 2015; Lain, 20 16). Through this lack of 
resources and improper recognition of personal need for resources, the difference 
between anxiety rates between MCI populations and control populations can be expected. 
It can also be seen that the UA MCI population will have the most anxiety reported 
throughout all the groups assessed which is also seen within the data. 
This conclusion lays into the next theory for why we see similar anxiety rates 
among MCI groups in the United States and Ukraine. This deals with the mortality rate 
that may increase anxiety. Individuals with MCI have increased mortality rates when 
compared to cognitively normal older adults (Guehne et al., 2006; Strand et al., 2018). 
Individuals also have increased mortality rates when they experience life stress, lack of 
social supports, and other factors that may lead to disease (Wilkinson & Marmot, 2008). 
These, as previously mentioned, effect the Ukrainian population more than the American 
population due to political and economic unrest in Ukraine. This concludes that the UA 
MCI population has the greatest potential mortality rate among the groups tested. This is 
shown because it has increased mortality rate through both means explained, presence of 
MCI diagnosis and increased life stress and lack of social supports. Anxiety along with 
other psychiatric disorders can result from knowledge of the death due to chronic illness 
(Shepherd et al., 1964). These results imply that increased mortality rate can lead to 
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increased anxiety. This study by Shepherd and colleges has been expanded on to include 
knowledge of increased death related anxiety within populations with dementia (Wilson 
et al., 2007). If MCI is considered an intennediate of dementia, the psychological 
symptoms experienced should also follow this similar trajectory (Lyketsos et al., 2002). 
So, if dementia patients have increased death related anxiety and MCI is an intermediate 
of dementia then death related anxiety should be increased in MCI populations too. This 
should prominently effect populations which have increased mortality rates, like the UA 
MCI group. It has been shown that this group has significantly more anxiety than both the 
US MCI and the UA control, therefore supporting this theory. 
Finally, my last proposed theory is that the methods used here do not account for 
cultural variance. The results show that the MoCA test still correctly identifies MCI and 
control populations. The results from the Kellner Symptom Questionnaire do not show 
the results expected. The MCI groups did not show similar results, while the control 
group and the US MCI group did. This may mean that the test, although there was an 
attempt to maximize validity via independent translation, did not collect information from 
the Ukrainian participants in the same way it did in the American population. This may 
mean that the tests is not valid in Ukrainian or that the test does not accurately assess the 
anxiety symptoms the Ukrainian population may face. 
Addition Analysis. It is apparent that there is a need to explore potential 
mediating or moderating variables that may explain the differences in the anxiety of the 
UA MCI and US MCI groups. To accomplish this, hierarchical regression modeling only 
including the MCI participants was used to predict anxiety while controlling for these 
variables. The regression modeling suggests that when accounting for gender and overall 
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cognitive level, the location of subjects (UA vs. US) is not predictive of their anxiety. 
This indicates that the difference in anxiety between the UA and US MCI groups may be 
related to the significant differences found between the demographic variables of the 
groups. See table 2. The first two theories presented above explain that the location 
should be a significant predictor of anxiety. Therefore, these results support the third 
hypothesis presented. This claims that the anxiety symptoms faced by both the UA 
populations were not properly assessed through the tests given. 
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Table 2. Regression Modeling among Location and Anxiety while Controlling for 
Age, Gender, Years of Education, and Cognitive Level (MoCA total). Variables' B (SE) (Constant) 9.28 (2.88) Age -0.04 (0.03) Gender 1 . 1 9  (0.52) Years of Education -0. 1 4  (0.09) R1Change F Ratio for R1 Change (Constant) 1 5.50 (3.86) Age -0.07 (0.04) Gender 1 .26 (0.5 1 )  Years of Education -0. 1 1 (0.09) MoCA Total -0.20 (0.09) R1Change F Ratio for R1 Change (Constant) 15.32 (3.84) Age -0.04 (0.04) 
Gender 1 .0 1  (0.53) Years of Education -0.09 (0.09) MoCA Total -0.2 1 (0.09) Location - 1 .24 (0.76) R1 Change F Ratio for W Change Anxiety 0.06 4. 19"'* 0.02 5.75* 0.01 2.65 p -0.07 0. 1 6* -0. 1 1  -0. 1 3  0. 1 7* -0.08 -0. 1 7* -0.07 0. 1 4  -0.07 -0. 18* -0. 1 3  'Note: Location coded as Ukraine = I ,  USA = 2 .  Gender was coded as Male = 0, Female = I ,  and Not Specified = 2. All groups (MCI and Control) included in the analysis. •p .5. 0.05, "'*p S 0.0 I, *"'*p S 0.00 I 
Significance 
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This research brings many issues into the light. Firstly, these issues draw to light 
the need for future research. One of the issues lay in the lack of research done with a MCI 
population in Ukraine. Currently there is one study which focused on a Ukrainian MCI 
population and the anxiety they may face (Levada et al., 2017). There was an attempt to 
look into research done in surrounding states or within specific ethnic populations that 
exists in these countries. Again, no research could be found. This means this study 
functions to a draw attention to the lack of work done with this population and spark 
interests regarding this individuals. There is also need to do research in dissimilar 
countries which have different cultures, economies, and geographic locations. This could 
help define what measures which are developed and currently in use in one population 
could be most beneficial to the other. For example, this could be used to motivate a 
validation of the SQ in Ukrainian. This leads to the second implementation of the 
findings here, a clinical setting. These findings highlight the need to screen MCI patients 
for anxiety. These individuals could feel anxiety for a variel)' of reasons and 
identification of these issues, despite their nationality, is beneficial to them. Furthennore, 
these findings could be used to infonn practitioners of prevalence of anxiety symptoms 
and how these may be different in particular populations. 
Limitations 
Primarily the limitations occur with mediating variables. There may be 
unassessed variables which were unable to be accurately translated to and from Ukrainian 
to be included here. This includes a variety of questions given as part of the demographic 
survey. Beyond this, there could be unaccounted variables like brain injury or chronic 
illness. There is also a possibility for inaccurate translation of items in the SQ and the 
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demographic survey that were included within the data analysis. These effects were 
minimized by independent translation but could potentially still effect results. There 
could also be more data published regarding Ukrainian and other Eastern European 
populations which could have guided the research preformed here. The data review done 
for this analysis was limited to articles written in English, excluding articles which could 
have been influential. 
Conclusion 
In summary, there was a significant difference between MoCA scores between 
MCI and control populations. There was also not a significant difference between anxiety 
rates between aMCI and naMCI. There was a significant difference in the anxiety rates 
between the US MCI and UA MCI groups while there was no significant difference 
between US MCI group and UA control. This can be explained through limited use or 
availability of help, increased death related anxiety, or, an inability to accommodate 
cultural variance. These results could be used to motivate research in this area and 
demonstrate the significance of screening to clinicians. There is also a clinically different 
type of anxiety within the MCI group. Both US and UA MCI groups have anxiety within 
the substantial- severe range. 
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